referral hospital, and urological clinics in several secondary and tertiary care centres.
Patients-933 of 1001 patients treated by lithotripsy at the lithotripter centre were compared with 195 treated by nephrolithotomy. Missing patients were due to incomplete collection of data. Age and sex distributions and characteristics of the stones were similar in the two treatment groups. Two patients died in the lithotripsy group. Three month follow up was achieved in about 84% of both groups (783/933 for lithotripsy; 163/195 for nephrolithotomy).
Interventions-The nephrolithotomy group had surgical nephrolithotomy alone. In the lithotripsy group 83% (774/933) had lithotripsy alone, 11% (103/ 933) had combined lithotripsy and nephrolithotomy, and 6% (56/933) had lithotripsy plus ureteroscopy. Single and combined lithotripter treatments were analysed as one group and compared with nephrolithotomy.
End point-Presence of stones three months after treatment.
Measurements and main results-Presence of residual stones was assessed by plain radiography, ultrasonography, or intravenous urography. After adjustment for age and size and position of stone for patients with single stones the likelihood of being free of stones three months after treatment was significantly greater in the nephrolithotomy group than the lithotripsy group (odds ratio ; 95% confidence interval 3-0 to 14.6 ) and the response was particularly pronounced with staghorn calculi (62% (8/13) v 15% (141/96) patients free of stones after nephrolithotomy and lithotripsy, respectively).
Otherfindings-19% (146/775) ofpatients who had had lithotripsy had to be readmitted within three months after treatment compared with 14% (23/162) who had nephrolithotomy; and 64% (94/146) of readmissions after lithotripsy were for complications compared with 30% (7/23) ofreadmissions after nephrolithotomy.
Conclusions-Nephrolithotomy may be preferable to lithotripsy for treating renal stones and it may not be wise to invest heavily in lithotripsy facilities.
Introduction
Between (9) of patients with single, multiple, and staghorn stones was almost identical between the two groups. In the 62% of patients treated by lithotripsy and the 61% of patients treated by nephrolithotomy who had a single stone the size and location of the stones was compared (table II) . The patients treated by nephrolithotomy had slightly smaller stones on average, but again the differences were small and not significant. A slightly higher proportion of the patients treated by nephrolithotomy had stones more than 30 mm in diameter (6% v 2%). The position of the stone was the only noteworthy discrepancy between the two groups. A substantially higher proportion of the single stones in patients treated by extracorporeal shock wave lithotripsy were in the upper or middle calix. (334) of the group treated by extracorporeal shock wave lithotripsy were day patients transferred from other London hospitals, to which they were returned immediately after treatment. The mean length of stay (excluding readmissions) was slightly longer for patients having percutaneous nephrolithotomy (9-0 v 7-9 days), but half (392/792) the patients treated by extracorporeal shock wave lithotripsy stayed in hospital for four days or less compared with only a quarter (48/ 194) of the patients treated by percutaneous nephrolithotomy. The modal length of stay for extracorporeal shock wave lithotripsy was two days (range 1-64 days) compared with four days for percutaneous nephrolithotomy (range 1-46 days). The ratio of the geometric mean length of stay for nephrolithotomy (7-2 days) and shock wave lithotripsy (5*4 days) was 1-3 (95% confidence interval 1-2 to 1 5).
Mortali'y-No patient died in the group treated with percutaneous nephrolithotomy either during the initial stay in hospital or up to three months after treatment. Two patients died in the other group: one in hospital and one between discharge and the three month follow up of coronary thrombosis and myocardial infarction, respectively. The mortality in the two treatment groups, which had a similar distribution of age, was not significantly different.
Complications-The observed rate of postoperative complications was lower in the patients treated by percutaneous nephrolithotomy (table III) . An almost total lack of obstruction from fragments was seen after percutaneous nephrolithotomy. Infections of the urinary tract were more common after percutaneous nephrolithotomy, though septicaemia was more common after extracorporeal shock wave lithotripsy. Altogether 84% (783) of the patients treated by extracorporeal shock wave lithotripsy and 84% (163) of the patients treated by percutaneous nephrolithotomy were successfully followed up at three months. Seventy eight (10%) patients treated by lithotripsy were reported to have suffered obstruction from fragments during this time, whereas obstruction was not reported in any patient treated by percutaneous nephrolithotomy (table IV) BMJ VOLUME 297 Outcome adjusting for patients' age and characteristics ofstones-About 60% of the patients in each group had single stones. Multiple logistic regression was used to compare the outcome of the two treatments for single stones, adjusting for differences in the patients' age, and the size and position of the stone between the two groups. The strong association between the mode of treatment (extracorporeal shock wave lithotripsy v percutaneous nephrolithotomy) and outcome (being free of stones v not being free of stones) observed previously remained, and the estimated relative efficacy of percutaneous nephrolithotomy against extracorporeal shock wave lithotripsy was increased from 4-6 (95% confidence interval 2-5 to 8-5) to 6-6 (95% confidence interval 3 0 to 14 6).
Readmissions-Another measure of the incidence and severity of complications between discharge and three months and of the significance of the lower rates of being free of stones in the group treated by extracorporeal shock wave lithotripsy was given by the incidence of readmission to hospital in the two groups. Altogether 19% (146/775) of the patients treated by extracorporeal shock wave lithotripsy had been readmitted at least once by the time of the three month follow up compared with 14% (23/162) of those treated by percutaneous nephrolithotomy. A far higher proportion of the readmissions in patients treated by extracorporeal shock wave lithotripsy were for complications rather than being planned readmissions (64% (94/146) v 30% (7/23)). The mean length of stay of readmissions, however, was the same in both groups (-5 days) . This is surprisingly low, given that half (11/23) 1985) , and extracorporeal shock wave lithotripsy (in 1985).) Their study was based on historical controls and they used different criteria to judge the success of the different treatments. They concluded that extracorporeal shock wave lithotripsy was better than both open surgery and percutaneous nephrolithotomy for most types of stone except cystine and staghorn calculi. Ninety per cent of the patients treated by extracorporeal shock wave lithotripsy and a combination of lithotripsy and percutaneous nephrolithotomy were described as successfully treated at three months as against 83% of the patients treated by percutaneous nephrolithotomy; 24% of 350 patients treated by lithotripsy had "gravel" but no adverse clinical effects. The rates of success of the three modes of treatment for all sizes of stones were not, however, significantly different and no information was given on potentially important variables such as the position of the stone. The three groups of patients had stones which were dissimilar in size. Furthermore, for percutaneous nephrolithotomy success was defined as being free of stones at three months, as in our study, whereas for extracorporeal shock wave lithotripsy success was equated with the fragmentation of stones into particles less than 2 mm in diameter.
Although the proportion of subjects who were free of stones after treatment was the traditional yardstick of success of treatments for renal stones before extracorporeal shock wave lithotripsy, many of the more impressive reports of success with extracorporeal shock wave lithotripsy have been based on less stringent criteria.3 Until more is known of the long term consequences and rates of recurrence associated with retained small fragments it is premature to assume that such fragments are benign. Thus, the rate of being free of stones should be used as the appropriate measure of success.
Three other studies of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy gave rates of being free of stones. In all three comparison with our study has difficulties in the comparability of the stones treated and the number of patients lost to follow up. In a Swedish study currently continuing at Linkoping 49% of patients treated by extracorporeal shock wave lithotripsy were free of stones at four weeks (B Jonsson, joint EHPF and World Health Organisation meeting, Brussels, 1987), compared with 45% of such patients in our study. This suggests a better outcome in Sweden as, apart from the proportion of staghorn stones, the stones were on average larger than those in our study. In two American studies the rates of being free ofstones were higher than those from either Linkoping or St Thomas's. Riehle The data on length of stay for the two methods of treatment are not easy to interpret. The mean length of stay for lithotripsy was high, 7-9 days, but the mode was only two days. This suggests that many patients were staying only a short time for their treatment. A few patients who stayed a long time raised the mean, but the reasons for these long stays were not recorded.
The long term effects of extracorporeal shock wave lithotripsy are unknown. The consequences for recurrence of stones of the high prevalence of debris in the group treated by extracorporeal shock wave lithotripsy (37% at three months) need to be carefully monitored. This is a worrying feature of extracorporeal shock wave lithotripsy as it is generally accepted that residual fragments after open surgery or percutaneous nephrolithotomy result in a greatly increased rate of recurrence requiring further treatment.'5 Some evidence of short term effects on renal function exists, [16] [17] [18] and the possibility of long term adverse consequences cannot be ruled out. Hypertension is also a possibility. As part of the current study clinical data are being collected on patients treated by shock wave lithotripsy at six, 12, and 24 months after discharge. Data on the costs of treatment and on patients' experiences of treatment, which are required to evaluate the two treatments fully, have been collected and will be reported separately.
CONCLUSIONS
Despite the lack of published evidence of the comparative merits of percutaneous nephrolithotomy and extracorporeal shock wave lithotripsy in which differences among patients and stones have been taken into account, the Scottish National Specialist Services Advisory Committee recommended in 1987 that a national lithotripsy service should be set up for Scotland, on the grounds that extracorporeal shock wave lithotripsy was 90% effective and less stressful for the patient than alternative methods of treatment. '9 Plans are already well advanced to install new generation lithotripters for treating renal stones in a number ofNHS regions. Lithotripsy is currently being brought into clinical practice for the destruction of gall stones. Yet the more extravagant claims made for extracorporeal shock wave lithotripsy were not upheld in our study of routine practice. 281 808 births in ali. The overali rates of late fetal death and early neonatal mortality were 3*5 and 3*1 per 1000, respectively. About 30% of the pregnant women were recorded as being daily smokers. Logistic regression analyses showed significant relative risks for late fetal death for high maternal age (1.4), nulliparity (1-4), multiparity (-2) (1.3), smoking (1-4), and multiple births (2.8). Significant relative risks for early neonatal mortality were found for multiple births (4.9) and smoking (1-2). Smokers aged under 35 faced a relative risk of late fetal death ranging from 1.1 to 1I6, while the risk for late fetal death was doubled i; the mothers were aged 35 years or more and smoked.
In countries like Sweden, where maternal cigarette smoking is prevalent, smoking may be the most important preventable risk factor for late fetal death.
Introduction
The causal association between maternal cigarette smoking and low birth weight is generally accepted, whereas the association between smoking and perinatal death is disputed.' In a review article McIntosh has reported that only five of 17 studies have found significantly increased risks of stillbirth among smokers.2 An increased risk of early neonatal death among the infants of smokers was reported in four studies, though none reached significance. The results of a large study of more than 360 000 single births in Missouri, United States, have also recently been published.3 In the multivariate analyses performed a significant effect of smoking on late fetal death and neonatal mortality (0-28 days) was seen. It has further been suggested that the risk of perinatal death related to smoking may not be equally distributed: it has been reported to vary with such factors as maternal age, parity, ethnic group, and socioeconomic state. 4 The above studies, including the Missouri study, were based on retrospectively collected data from fairly heterogeneous populations that had perinatal mortality rates ranging from 12 to 30 per 1000.
In Sweden the overall perinatal mortality is below seven per 1000. The population is homogeneous, with poverty and undernutrition practically non-existent in the pregnant population. Antenatal and obstetric care is free, and practically all pregnant women visit the antenatal clinics regularly during pregnancy and give birth at hospitals.' Thus Sweden provides an excellent opportunity to study late fetal death and early neonatal mortality resulting from biological variation and specific environmental influences in a well nourished population.
In 1973 a medical birth registry was set up by the National Board of Health and Welfare in Sweden. 6 Since 1982 information has been prospectively collected for each pregnancy from the first antenatal visit. These
